Anika Therapeutics, Inc. (ANIK)
14.91
+0.16
(+1.08%)
USD |
NASDAQ |
Apr 07, 16:00
14.91
0.00 (0.00%)
After-Hours: 17:39
Anika Therapeutics Accounts Receivable (Annual) : 23.69M for Dec. 31, 2025
Accounts Receivable (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Annual) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 106.82M |
| Lantheus Holdings, Inc. | 358.64M |
| TELA Bio, Inc. | 10.35M |
| Plus Therapeutics, Inc. | 0.322M |
| BioStem Technologies, Inc. | 9.874M |